AFOs Improve Stride Length and Gait Velocity but Not Motor Function for Most with Mild Cerebral Palsy

Sensors (Basel). 2023 Jan 4;23(2):569. doi: 10.3390/s23020569.

Abstract

Ankle-foot orthoses (AFOs) are prescribed to children with cerebral palsy (CP) in hopes of improving their gait and gross motor activities. The purpose of this retrospective study was to examine if clinically significant changes in gross motor function occur with the use of AFOs in children and adolescents diagnosed with CP (Gross Motor Function Classification System levels I and II). Data from 124 clinical assessments were analyzed. Based on minimum clinically important difference (MCID), 77% of subjects demonstrated an increase in stride length, 45% of subjects demonstrated an increase in walking velocity, and 30% demonstrated a decrease in cadence. Additionally, 27% of the subjects demonstrated increase in gait deviation index (GDI). Deterioration in gait was evident by decreases in walking speed (5% of subjects), increases in cadence (11% of subjects), and 15% of subjects demonstrated decreases in gait deviation index. Twenty-two percent of subjects demonstrated no change in stride lengths and one participant demonstrated a decrease in stride length. However, AFOs improved Gross Motor Function Measure (GMFM) scores for a minority (10%) of children with mild CP (GMFCS level I and II), with 82-85% of subjects demonstrating no change in GMFM scores and 5-7% demonstrating decrease in GMFM scores.

Keywords: ankle–foot orthosis; cerebral palsy; gait analysis; minimum clinically important difference; motor function; over ground walking.

MeSH terms

  • Adolescent
  • Cerebral Palsy*
  • Child
  • Gait
  • Humans
  • Orthotic Devices
  • Retrospective Studies
  • Walking

Grants and funding

This research received no external funding.